IMMUNE GLOBULIN NOS for Immunodeficiency common variable: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 15 adverse event reports in the FDA FAERS database where IMMUNE GLOBULIN NOS was used for Immunodeficiency common variable.
Most Reported Side Effects for IMMUNE GLOBULIN NOS
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 963 | 42.8% | 228 | 533 |
| Off label use | 675 | 30.0% | 113 | 334 |
| Drug ineffective for unapproved indication | 266 | 11.8% | 69 | 143 |
| Condition aggravated | 207 | 9.2% | 31 | 138 |
| Product use in unapproved indication | 143 | 6.4% | 31 | 52 |
| Therapy non-responder | 130 | 5.8% | 14 | 82 |
| Treatment failure | 121 | 5.4% | 12 | 36 |
| Septic shock | 95 | 4.2% | 31 | 86 |
| Diarrhoea | 92 | 4.1% | 9 | 74 |
| Maternal exposure during pregnancy | 83 | 3.7% | 1 | 40 |
| Vomiting | 83 | 3.7% | 6 | 67 |
| Nausea | 81 | 3.6% | 4 | 54 |
| Drug intolerance | 77 | 3.4% | 1 | 67 |
| Disease progression | 67 | 3.0% | 14 | 22 |
| Intentional product use issue | 67 | 3.0% | 14 | 37 |
Other Indications for IMMUNE GLOBULIN NOS
Product used for unknown indication (292)
Immune thrombocytopenia (100)
Haemophagocytic lymphohistiocytosis (98)
Immunosuppressant drug therapy (98)
Dermatomyositis (92)
Covid-19 (83)
Myasthenia gravis (63)
Encephalitis autoimmune (52)
Interstitial lung disease (48)
Juvenile idiopathic arthritis (47)
Other Drugs Used for Immunodeficiency common variable
HUMAN IMMUNOGLOBULIN G (17,389)
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN (1,598)
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE (881)
GAMMAGARD LIQUID (81)
HIZENTRA (76)
DUPILUMAB (69)
RITUXIMAB (44)
INFLIXIMAB (28)
PREDNISOLONE (27)
HUMAN C1-ESTERASE INHIBITOR (24)